INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 105 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $28,000 | +3.7% | 13,488 | +0.6% | 0.00% | – |
| Q4 2017 | $27,000 | +35.0% | 13,406 | -11.1% | 0.00% | – |
| Q3 2017 | $20,000 | -16.7% | 15,080 | +0.0% | 0.00% | – |
| Q2 2017 | $24,000 | -54.7% | 15,078 | -9.8% | 0.00% | – |
| Q1 2017 | $53,000 | +140.9% | 16,714 | +0.1% | 0.00% | – |
| Q4 2016 | $22,000 | -15.4% | 16,702 | +0.3% | 0.00% | – |
| Q3 2016 | $26,000 | -99.2% | 16,655 | -90.9% | 0.00% | -100.0% |
| Q4 2014 | $3,107,000 | +22.0% | 183,942 | -0.2% | 0.01% | 0.0% |
| Q4 2013 | $2,546,000 | -8.7% | 184,336 | +15.3% | 0.01% | -20.0% |
| Q3 2013 | $2,789,000 | +43.2% | 159,816 | +33.4% | 0.01% | +25.0% |
| Q2 2013 | $1,947,000 | – | 119,809 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
| EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
| ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |